Predict
Activity
Cohort
Portfolio
Support
Search anything…
Ctrl
K
Log in
FDA approves Retatrutide this year?
$569.75K Vol.
|
Dec 31, 2026
12%
chance
1H
6H
1D
1W
1M
ALL
Outcome
$569.75K Vol.
13%
Buy Yes
1
3
¢
13¢
Buy No
8
8
¢
88¢
Holders
Activity
Comments
3
Outcome
Filter
Trader
Outcomes
Invested
Total PnL
ROI
Open PnL
Buy
Sell
Limit
Yes
1
3
¢
13¢
No
8
8
¢
88¢
Limit Price
¢
Shares
Max
-100
-10
+10
+100
+1,000
Expires
Never
Buy Yes